应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CDTX Cidara Therapeutics, Inc.
交易中 05-05 10:04:00 EDT
21.45
-0.24
-1.11%
最高
21.99
最低
21.45
成交量
5,854
今开
21.55
昨收
21.69
日振幅
2.49%
总市值
2.69亿
流通市值
1.11亿
总股本
1,255万
成交额
12.71万
换手率
0.11%
流通股本
516.91万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Cidara Therapeutics, Inc.盘中异动 大幅下挫5.30%
市场透视 · 04-30
Cidara Therapeutics, Inc.盘中异动 大幅下挫5.30%
Cidara Therapeutics, Inc.盘中异动 早盘股价大跌5.04%
市场透视 · 04-29
Cidara Therapeutics, Inc.盘中异动 早盘股价大跌5.04%
Cidara Therapeutics, Inc.盘中异动 快速上涨5.49%报21.82美元
市场透视 · 04-22
Cidara Therapeutics, Inc.盘中异动 快速上涨5.49%报21.82美元
Cidara Therapeutics, Inc.盘中异动 大幅跳水5.00%
市场透视 · 04-16
Cidara Therapeutics, Inc.盘中异动 大幅跳水5.00%
Cidara Therapeutics, Inc.盘中异动 下午盘大幅跳水6.04%
市场透视 · 03-10
Cidara Therapeutics, Inc.盘中异动 下午盘大幅跳水6.04%
Cidara Therapeutics(CDTX.US):2024年Q4财报实现营收0美元,前值为1758.3万美元,预期值为30万美元;每股收益为-5.38美元,前值为-0.80美元,预期值为-4.10美元。
金融界 · 03-06
Cidara Therapeutics(CDTX.US):2024年Q4财报实现营收0美元,前值为1758.3万美元,预期值为30万美元;每股收益为-5.38美元,前值为-0.80美元,预期值为-4.10美元。
Cidara Therapeutics 2024年第四季度GAAP每股收益$(5.37),低于预期$(3.62)
财报速递 · 03-06
Cidara Therapeutics 2024年第四季度GAAP每股收益$(5.37),低于预期$(3.62)
Cidara Therapeutics, Inc.盘中异动 急速上涨5.03%
市场透视 · 02-28
Cidara Therapeutics, Inc.盘中异动 急速上涨5.03%
Cidara Therapeutics, Inc.盘中异动 大幅上涨5.07%报22.51美元
市场透视 · 02-26
Cidara Therapeutics, Inc.盘中异动 大幅上涨5.07%报22.51美元
Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.02%报21.53美元
市场透视 · 02-25
Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.02%报21.53美元
Cidara Therapeutics, Inc.盘中异动 早盘急速下跌5.27%
市场透视 · 02-24
Cidara Therapeutics, Inc.盘中异动 早盘急速下跌5.27%
Cidara Therapeutics, Inc.盘中异动 急速拉升5.43%报22.91美元
市场透视 · 02-11
Cidara Therapeutics, Inc.盘中异动 急速拉升5.43%报22.91美元
Cidara Therapeutics, Inc.盘中异动 急速拉升5.79%报21.39美元
市场透视 · 02-06
Cidara Therapeutics, Inc.盘中异动 急速拉升5.79%报21.39美元
坎托菲茨杰拉德公司:假定Cidara Therapeutics(CDTX.US)增持评级。
金融界 · 01-27
坎托菲茨杰拉德公司:假定Cidara Therapeutics(CDTX.US)增持评级。
Cidara Therapeutics, Inc.盘中异动 早盘急速下跌5.87%
市场透视 · 01-24
Cidara Therapeutics, Inc.盘中异动 早盘急速下跌5.87%
Cidara Therapeutics, Inc.盘中异动 临近午盘股价大涨6.37%
市场透视 · 01-16
Cidara Therapeutics, Inc.盘中异动 临近午盘股价大涨6.37%
Cidara Therapeutics, Inc.盘中异动 股价大跌8.44%
市场透视 · 01-08
Cidara Therapeutics, Inc.盘中异动 股价大跌8.44%
Cidara Therapeutics, Inc.盘中异动 早盘大幅下跌6.92%
市场透视 · 01-03
Cidara Therapeutics, Inc.盘中异动 早盘大幅下跌6.92%
Cidara Therapeutics, Inc.盘中异动 临近午盘大幅上涨5.12%报28.26美元
市场透视 · 01-02
Cidara Therapeutics, Inc.盘中异动 临近午盘大幅上涨5.12%报28.26美元
Cidara Therapeutics, Inc.盘中异动 临近午盘股价大涨5.74%报26.70美元
市场透视 · 2024-12-31
Cidara Therapeutics, Inc.盘中异动 临近午盘股价大涨5.74%报26.70美元
加载更多
公司概况
公司名称:
Cidara Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Cidara Therapeutics, Inc.原本以K2 Therapeutics公司的名字于2012年12月在特拉华州注册成立,2014年7月更名为Cidara Therapeutics公司。公司是一家生物技术公司,专注于发现,开发和商业化新的抗感染剂用于治疗疾病是由护理疗法目前标准充分解决。 CD101是棘白菌素类,一类成熟的抗真菌剂。该公司最初的专有候选产品是其新化合物,CD101,对于严重的真菌感染的治疗配方。该公司的第一个产品是候补CD101静脉内,以前biafungin,一个潜在的每周一次静脉内,或IV,治疗被用于全身性真菌感染的治疗和预防的发展。该公司的第二个候选产品,CD101外用,原名topifungin,是一种外用制剂CD101用于治疗外阴阴道念珠菌病,或VVC,一个普遍的粘膜感染。 CD101局部是棘白菌素类抗真菌剂中的所述第一局部施用。此外,该公司已开发出专有的免疫治疗技术平台,CloudbreakTM,它用它来创建,旨在引导患者的免疫细胞来攻击和消灭病原体引起的感染性疾病的化合物。该公司正在开发其第一个断云开发的候选人,C001,用于治疗侵袭性曲霉病,引起真菌病原体,曲霉菌感染。公司正在评估更多的机会来扩大其断云免疫平台,传染病等领域。
发行价格:
--
{"stockData":{"symbol":"CDTX","market":"US","secType":"STK","nameCN":"Cidara Therapeutics, Inc.","latestPrice":21.45,"timestamp":1746453817338,"preClose":21.69,"halted":0,"volume":5854,"delay":0,"floatShares":5169100,"shares":12546700,"eps":-26.745962,"marketStatus":"交易中","change":-0.24,"latestTime":"05-05 10:04:00 EDT","open":21.55,"high":21.99,"low":21.45,"amount":127144.84074,"amplitude":0.024896,"askPrice":21.92,"askSize":180,"bidPrice":21.4,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-26.745962,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746475200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1429070400000,"exchange":"NASDAQ","adjPreClose":21.69,"preHourTrading":{"tag":"盘前","latestPrice":21.22,"preClose":21.69,"latestTime":"04:17 EDT","volume":2,"amount":42.32,"timestamp":1746433063407},"postHourTrading":{"tag":"盘后","latestPrice":21.69,"preClose":21.69,"latestTime":"18:46 EDT","volume":203,"amount":4403.07,"timestamp":1746226008269},"volumeRatio":0.582786,"impliedVol":1.8674,"impliedVolPercentile":0.9792},"requestUrl":"/m/hq/s/CDTX","defaultTab":"news","newsList":[{"id":"2532065489","title":"Cidara Therapeutics, Inc.盘中异动 大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532065489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532065489?lang=zh_cn&edition=full","pubTime":"2025-05-01 00:36","pubTimestamp":1746031002,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日00时36分,Cidara Therapeutics, Inc.股票出现波动,股价快速下挫5.30%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。其相关个股中,Regulus Therapeutics Inc.、Abeona Therapeutics Inc.、Nutriband Inc.涨幅较大,Purple Biotech Ltd、Regulus Therapeutics Inc.、Onconetix, Inc.较为活跃,换手率分别为160.34%、33.64%、24.88%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Abeona Therapeutics Inc.、Sol-Gel Technologies Ltd.,振幅分别为56.00%、37.52%、33.18%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501003642974bc5ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501003642974bc5ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CDTX"],"gpt_icon":0},{"id":"2531804758","title":"Cidara Therapeutics, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531804758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531804758?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:30","pubTimestamp":1745933455,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时30分,Cidara Therapeutics, Inc.股票出现异动,股价快速跳水5.04%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.涨幅较大,Zyversa Therapeutics, Inc.、Onconetix, Inc.、Abeona Therapeutics Inc.较为活跃,换手率分别为128.55%、37.37%、10.80%,振幅较大的相关个股有Promis Neurosciences Inc.、Sutro Biopharma, Inc.、Genprex, Inc.,振幅分别为9.62%、5.19%、4.98%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213055a46c3ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213055a46c3ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CDTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2529921534","title":"Cidara Therapeutics, Inc.盘中异动 快速上涨5.49%报21.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529921534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529921534?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:30","pubTimestamp":1745339439,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时30分,Cidara Therapeutics, Inc.股票出现波动,股价大幅拉升5.49%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.01%。其相关个股中,Moolec Science Sa C/Wts 、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Portage Biotech Inc.涨幅较大,Ocean Biomedical, Inc.、Portage Biotech Inc.、Scorpius Holdings, Inc.较为活跃,换手率分别为208.81%、145.65%、145.33%,振幅较大的相关个股有Scorpius Holdings, Inc.、Moolec Science Sa C/Wts 、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为102.79%、89.29%、75.29%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423003039aa2c76c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423003039aa2c76c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CDTX","LENZ"],"gpt_icon":0},{"id":"2528227893","title":"Cidara Therapeutics, Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528227893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528227893?lang=zh_cn&edition=full","pubTime":"2025-04-17 00:27","pubTimestamp":1744820820,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日00时27分,Cidara Therapeutics, Inc.股票出现波动,股价大幅下挫5.00%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.21%。其相关个股中,Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dermata Therapeutics Inc C/Wts 涨幅较大,Briacell Therapeutics Corp.、Transcode Therapeutics, Inc.、Pmgc Holdings Inc.较为活跃,换手率分别为500.11%、246.29%、179.82%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Dermata Therapeutics Inc C/Wts ,振幅分别为90.48%、49.00%、36.67%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417002700aa2c71cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417002700aa2c71cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CDTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2518221205","title":"Cidara Therapeutics, Inc.盘中异动 下午盘大幅跳水6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518221205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518221205?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:58","pubTimestamp":1741629503,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时58分,Cidara Therapeutics, Inc.股票出现波动,股价急速下挫6.04%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.85%。其相关个股中,Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃,换手率分别为5624.76%、3827.78%、992.55%,振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc,振幅分别为90.44%、88.14%、58.34%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101582396406b31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101582396406b31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CDTX"],"gpt_icon":0},{"id":"2517583114","title":"Cidara Therapeutics(CDTX.US):2024年Q4财报实现营收0美元,前值为1758.3万美元,预期值为30万美元;每股收益为-5.38美元,前值为-0.80美元,预期值为-4.10美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517583114","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517583114?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:57","pubTimestamp":1741301845,"startTime":"0","endTime":"0","summary":"Cidara Therapeutics(CDTX.US):2024年Q4财报实现营收0美元,前值为1758.3万美元,预期值为30万美元;每股收益为-5.38美元,前值为-0.80美元,预期值为-4.10美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07065748578836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CDTX","LENZ"],"gpt_icon":0},{"id":"1150749820","title":"Cidara Therapeutics 2024年第四季度GAAP每股收益$(5.37),低于预期$(3.62)","url":"https://stock-news.laohu8.com/highlight/detail?id=1150749820","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150749820?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:41","pubTimestamp":1741297272,"startTime":"0","endTime":"0","summary":"Cidara Therapeutics报告季度每股亏损$,低于分析师普遍预期的$,低48.34%。相比去年同期每股亏损$,下降了656.34%。以上内容来自Benzinga Earnings专栏,原文如下:Cidara $Therapeutics$ reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 48.34 percent. This is a 656.34 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cidara Therapeutics 2024年第四季度GAAP每股收益$(5.37),低于预期$(3.62)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDTX"],"gpt_icon":0},{"id":"2516966374","title":"Cidara Therapeutics, Inc.盘中异动 急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516966374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516966374?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:45","pubTimestamp":1740761152,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时45分,Cidara Therapeutics, Inc.股票出现波动,股价急速拉升5.03%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Camp4 Therapeutics Corporation涨幅较大,Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为2987.99%、493.03%、368.47%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为57.80%、48.19%、46.60%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010045529634388a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010045529634388a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2514850661","title":"Cidara Therapeutics, Inc.盘中异动 大幅上涨5.07%报22.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514850661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514850661?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:37","pubTimestamp":1740587850,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时37分,Cidara Therapeutics, Inc.股票出现异动,股价快速上涨5.07%。截至发稿,该股报22.51美元/股,成交量1.6672万股,换手率0.15%,振幅4.75%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.05%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003731a255143b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003731a255143b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2514013030","title":"Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.02%报21.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013030?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:04","pubTimestamp":1740495873,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时04分,Cidara Therapeutics, Inc.股票出现波动,股价急速上涨5.02%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.01%。其相关个股中,Lava Therapeutics N.V.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大,Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为1003.62%、575.88%、511.55%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nutriband Inc C/Wts ,振幅分别为47.10%、43.70%、42.76%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230433abdc865d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230433abdc865d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2513472722","title":"Cidara Therapeutics, Inc.盘中异动 早盘急速下跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513472722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513472722?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:40","pubTimestamp":1740408044,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时40分,Cidara Therapeutics, Inc.股票出现异动,股价大幅下跌5.27%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。其相关个股中,Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为65.99%、49.72%、24.56%,振幅较大的相关个股有Pepgen Inc.、Vaxart, Inc. - Common Stock、Telix Pharmaceutic,振幅分别为92.70%、21.42%、17.95%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242240449890f845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242240449890f845&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2510300043","title":"Cidara Therapeutics, Inc.盘中异动 急速拉升5.43%报22.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510300043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510300043?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:55","pubTimestamp":1739296547,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时55分,Cidara Therapeutics, Inc.股票出现波动,股价快速上涨5.43%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.41%。其相关个股中,Omega Therapeutics, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为3065.43%、1388.11%、466.10%,振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.,振幅分别为143.33%、59.66%、58.60%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212015548a242266f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212015548a242266f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CDTX"],"gpt_icon":0},{"id":"2509201469","title":"Cidara Therapeutics, Inc.盘中异动 急速拉升5.79%报21.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509201469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509201469?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:21","pubTimestamp":1738862461,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时21分,Cidara Therapeutics, Inc.股票出现异动,股价急速拉升5.79%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。其相关个股中,Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃,换手率分别为6115.80%、1625.43%、163.47%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为125.58%、58.37%、53.02%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207012101987ca830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207012101987ca830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDTX","LENZ"],"gpt_icon":0},{"id":"2506370684","title":"坎托菲茨杰拉德公司:假定Cidara Therapeutics(CDTX.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2506370684","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506370684?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:11","pubTimestamp":1737987063,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司:假定Cidara Therapeutics(CDTX.US)增持评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/27221147863000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CDTX"],"gpt_icon":0},{"id":"2505186459","title":"Cidara Therapeutics, Inc.盘中异动 早盘急速下跌5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505186459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505186459?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:57","pubTimestamp":1737730662,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时57分,Cidara Therapeutics, Inc.股票出现异动,股价快速下跌5.87%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。其相关个股中,Evaxion Biotech As、Pmgc Holdings Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃,换手率分别为2498.41%、1610.47%、884.29%,振幅较大的相关个股有Evaxion Biotech As、Pmgc Holdings Inc.、Windtree Therapeutics, Inc.,振幅分别为54.40%、52.53%、41.79%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225742987207a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225742987207a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CDTX","BK4139"],"gpt_icon":0},{"id":"2504120759","title":"Cidara Therapeutics, Inc.盘中异动 临近午盘股价大涨6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504120759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504120759?lang=zh_cn&edition=full","pubTime":"2025-01-17 00:47","pubTimestamp":1737046057,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日00时47分,Cidara Therapeutics, Inc.股票出现波动,股价急速上涨6.37%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Aeon Biopharma, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大,Aditxt, Inc.、Aeon Biopharma, Inc.、Phio Pharmaceuticals Corp.较为活跃,换手率分别为1843.09%、526.48%、410.04%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aeon Biopharma, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为131.33%、104.84%、76.46%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117004738a2247f1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117004738a2247f1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2501775533","title":"Cidara Therapeutics, Inc.盘中异动 股价大跌8.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501775533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501775533?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:42","pubTimestamp":1736347333,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时42分,Cidara Therapeutics, Inc.股票出现波动,股价大幅下跌8.44%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大,Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为1567.03%、537.49%、509.78%,振幅较大的相关个股有Silo Pharma, Inc.、Sana Biotechnology, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为135.78%、84.85%、68.53%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108224213a21a5656&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108224213a21a5656&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CDTX"],"gpt_icon":0},{"id":"2500114220","title":"Cidara Therapeutics, Inc.盘中异动 早盘大幅下跌6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500114220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500114220?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:51","pubTimestamp":1735915895,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时51分,Cidara Therapeutics, Inc.股票出现异动,股价大幅下跌6.92%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.涨幅较大,Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为1336.30%、881.81%、278.03%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.,振幅分别为143.91%、87.11%、85.72%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103225135a2146d9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103225135a2146d9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2500971508","title":"Cidara Therapeutics, Inc.盘中异动 临近午盘大幅上涨5.12%报28.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500971508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500971508?lang=zh_cn&edition=full","pubTime":"2025-01-03 00:39","pubTimestamp":1735835993,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日00时39分,Cidara Therapeutics, Inc.股票出现异动,股价大幅拉升5.12%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.80%。其相关个股中,Revelation Biosciences Inc C/Wts 10/01/2027 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Celularity Inc C/Wts 16/07/2026 涨幅较大,Revelation Biosciences, Inc.、Mustang Bio, Inc.、知临集团较为活跃,换手率分别为1172.16%、254.76%、195.20%,振幅较大的相关个股有Mustang Bio, Inc.、Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为146.61%、127.98%、125.71%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103003953ab9c142f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103003953ab9c142f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CDTX"],"gpt_icon":0},{"id":"2500161011","title":"Cidara Therapeutics, Inc.盘中异动 临近午盘股价大涨5.74%报26.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500161011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500161011?lang=zh_cn&edition=full","pubTime":"2025-01-01 00:52","pubTimestamp":1735663944,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日00时52分,Cidara Therapeutics, Inc.股票出现异动,股价急速上涨5.74%。Cidara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.18%。其相关个股中,知临集团、Seastar Medical Holding Corp C/Wts 28/10/2027 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,知临集团、Eyenovia, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1620.40%、293.20%、83.98%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、知临集团、Seastar Medical Holding Corp C/Wts 28/10/2027 ,振幅分别为248.39%、204.42%、82.71%。Cidara Therapeutics, Inc.公司简介:Cidara Therapeutics Inc 正在开发免疫治疗,旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101005224ab999c64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101005224ab999c64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cidara.com","stockEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.1807},{"period":"3month","weight":0.1677},{"period":"6month","weight":0.657},{"period":"1year","weight":0.7106},{"period":"ytd","weight":-0.1931}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cidara Therapeutics, Inc.原本以K2 Therapeutics公司的名字于2012年12月在特拉华州注册成立,2014年7月更名为Cidara Therapeutics公司。公司是一家生物技术公司,专注于发现,开发和商业化新的抗感染剂用于治疗疾病是由护理疗法目前标准充分解决。 CD101是棘白菌素类,一类成熟的抗真菌剂。该公司最初的专有候选产品是其新化合物,CD101,对于严重的真菌感染的治疗配方。该公司的第一个产品是候补CD101静脉内,以前biafungin,一个潜在的每周一次静脉内,或IV,治疗被用于全身性真菌感染的治疗和预防的发展。该公司的第二个候选产品,CD101外用,原名topifungin,是一种外用制剂CD101用于治疗外阴阴道念珠菌病,或VVC,一个普遍的粘膜感染。 CD101局部是棘白菌素类抗真菌剂中的所述第一局部施用。此外,该公司已开发出专有的免疫治疗技术平台,CloudbreakTM,它用它来创建,旨在引导患者的免疫细胞来攻击和消灭病原体引起的感染性疾病的化合物。该公司正在开发其第一个断云开发的候选人,C001,用于治疗侵袭性曲霉病,引起真菌病原体,曲霉菌感染。公司正在评估更多的机会来扩大其断云免疫平台,传染病等领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.020189},{"month":2,"riseRate":0.3,"avgChangeRate":-0.018232},{"month":3,"riseRate":0.5,"avgChangeRate":0.008463},{"month":4,"riseRate":0.3,"avgChangeRate":-0.079235},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.000043},{"month":6,"riseRate":0.4,"avgChangeRate":-0.014011},{"month":7,"riseRate":0.3,"avgChangeRate":0.006371},{"month":8,"riseRate":0.4,"avgChangeRate":0.011706},{"month":9,"riseRate":0.4,"avgChangeRate":0.017964},{"month":10,"riseRate":0.3,"avgChangeRate":-0.053421},{"month":11,"riseRate":0.6,"avgChangeRate":0.061206},{"month":12,"riseRate":0.5,"avgChangeRate":0.059112}],"exchange":"NASDAQ","name":"Cidara Therapeutics, Inc.","nameEN":"Cidara Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cidara Therapeutics, Inc.(CDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cidara Therapeutics, Inc.,CDTX,Cidara Therapeutics, Inc.股票,Cidara Therapeutics, Inc.股票老虎,Cidara Therapeutics, Inc.股票老虎国际,Cidara Therapeutics, Inc.行情,Cidara Therapeutics, Inc.股票行情,Cidara Therapeutics, Inc.股价,Cidara Therapeutics, Inc.股市,Cidara Therapeutics, Inc.股票价格,Cidara Therapeutics, Inc.股票交易,Cidara Therapeutics, Inc.股票购买,Cidara Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cidara Therapeutics, Inc.(CDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}